Navigation Links
Anti-Aging Powers of Enzyme Sirtuins

In the recent years, scientists discovered a family of enzymes called sirtuins, which can dramatically extend life in organisms// as diverse as yeast, worms, and flies.

Now, a new study from scientists at The Wistar Institute points to another strategy for activating sirtuins to unleash their anti-aging powers. They may also be able to control age-associated metabolic disorders, including obesity and type II diabetes.

Naturally occurring substances have been shown to activate sirtuins, including a constituent of red wine called resveratrol – although an individual would need to drink about two cases of wine a day to derive a clinically effective dose of resveratrol.

Still, the findings have energized a number of scientific groups and biotechnology companies, all of which are now eagerly searching for drug candidates able to boost sirtuin activity. The public-health benefits of such an "anti-aging" drug would be substantial – as would the economic returns.

A report on the research will appear in the February 9 edition of Molecular Cell, and a podcast interview with the study's senior author, Ronen Marmorstein, Ph.D., a professor in the Gene Expression and Regulation Program at Wistar, will be available on the Institute's web site (www.wistar.org) on the same date.

Using the techniques of structural biology, the Wistar team demonstrated that a component of the common vitamin B3, also known as niacin, binds to a specific site on the sirtuin molecule to inhibit its activity. This observation suggests that drugs designed to prevent the vitamin B3 component, nicotinamide, from binding at this site could have the effect of activating sirtuins. Any such drug would, in essence, inhibit the inhibitory effect of nicotinamide. As in mathematics, the two negatives would create a positive result – activation of sirtuins.

"Our findings suggest a new avenue for designing sirtuin-activating drugs," says Marmors
'"/>




Page: 1 2

Related medicine news :

1. Does Magnet Therapy Posses Healing Powers?
2. GMC Wrestles For Regulatory Powers
3. Soy’s Restorative Powers Confirme
4. Smart Sunglasses With Chameleon Powers
5. Enzyme may be target for obesity drugs
6. Researchers trick Alzheimers Enzyme
7. Enzyme stimulates growth of adult stem cells
8. Enzyme may aid hold back disease
9. Enzyme help destroy cancer cell
10. Enzyme Associated with Memory
11. Enzyme Associated With Memory

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Anti Aging Powers Enzyme Sirtuins

(Date:12/3/2009)...eart is stopped and restarted, the patient,s life ...damaged. Therapeutic hypothermia, a treatment in w... maintained several degrees below normal for a per...ful effects and improve survival in adults. , No...ts kind, physician-scientists are evaluating the e...
(Date:12/3/2009)...is still too many - stalled momentum puts millions... Atlanta, GA, Geneva, New York, NY and Washington,...tive announced today that measles deaths worldwide...ted 733 000 in 2000 to 164 000 in 2008. However, g... measles deaths if vaccination efforts are not sus...
(Date:12/3/2009)... to smoke are at risk of lung cancer , ,...al cancer to the list of malignancies caused by sm...ween the two. , And other studies are providing...uit: Two papers published in the December issue of...emed issue on tobacco, strengthen the case for the...
(Date:12/3/2009)...wire/ -- To help children better understand the fl...ntracting all forms of influenza, a new animated h...y and the Flu . ,, The DVD was created by the E... which is part of the Area Health Education Center...he U.S. Centers for Disease Control and Prevention...
(Date:12/3/2009)... -- This holiday season, families tired of watchin...ain are putting a different kind of gift under the...h minimally-invasive endoscopic surgery is now pos...ne Institute (LSI). With surgical facilities in T...onizing spinal procedures using a signature proces...
Breaking Medicine News(10 mins):Health News:Cooling may benefit children after cardiac arrest 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 3Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 4Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 2Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 3Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 4Health News:New Animated DVD Helps Children to Better Understand and Prevent Contracting the Flu 2Health News:Give the Gift of Relief for the New Year 2
...ing prostate cancer screen less useful, but some e...thDay News) -- Changes in medical practice have un...n (PSA) test as a diagnostic tool for prostate can... annual screening for prostate cancer for most men...
...um,Pharmaceuticals, Inc. (Nasdaq: MLNM ) today an...ny 28th Annual Healthcare Conference will be webca...ors section of the Company,s,website, http://www....b) for,Injection and product candidates in the dev...
... Non-Branded Web site, Best Branded Pharmac... WEST CONSHOHOCKEN, Pa., March 10 Cadient Group,...y serving the healthcare,industry, announced today...ards Dinner on April 17, 2008., "We are excited a...
...c. (NYSE:,NTY) (http://www.NBTY.com ), a leading ...pplements, today announced that it will web cast t...ef Financial Officer of,NBTY, at the Bank of Ameri....nbty.com on Tuesday, March 11, 2008 at 2:30 PM E...
...nts are now utilized,in thousands of consumer prod...a self-described ,tea think-tank, notes that non-b...redients now outnumber beverage,tea offerings on a... including, skincare preparations, functional,food...
...dical Technologies,today announced that the TETRA(...iven clearance to proceed with marketing efforts f...the US Food and Drug Administration,(USFDA)., Lab... be made available to the broadest urological and ...
Other Medicine News:Health News:PSA Test Losing Diagnostic Value, Study Says 2Health News:PSA Test Losing Diagnostic Value, Study Says 3Health News:Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium Presentation 2Health News:Cadient Group Receives Multiple Nominations for 2008 DTC National Advertising Awards 2Health News:NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares 2Health News:NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares 3Health News:Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products 2Health News:Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products 3Health News:Laborie Medical Technologies Receives FDA Pre-Market Clearance for TETRA(TM)- NIRS Accessory for the US Market 2
(Date:12/3/2009)... , HOERSHOLM, Denmark and SAN DIEGO, Cal...PC3649 Successfully Inhibits miR-122, a microRNA I...y Significantly Reducing Hepatitis C,Virus in the ...th the,Hepatitis C Virus , - SPC3649 Demo...ance and,No Serious Adverse Events in the Treated ...
(Date:12/3/2009)..., SAN DIEGO, Dec. 3 Card...y that its wholly-owned subsidiary, Tissue Repair ... filing with the U.S. Food and Drug Administration...en (TM) product candidate based on positive data ...rix clinical study. Today,s submission with the F...
(Date:12/3/2009)...PALO ALTO, Calif., Dec. 3 /PRNewswire-FirstCall/ -...unced today that Kathryn E. Falberg has been appoi...icer. Ms. Falberg brings to Jazz Pharmaceuticals ...or experience. As Jazz Pharmaceutical,s CFO, Ms. ...unting, corporate finance, financial planning, inv...
Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 1Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 2Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 3Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 4Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 5Drug side effects a key factor in reduced quality of life for kidney transplant patients 61930 1Drug side effects a key factor in reduced quality of life for kidney transplant patients 61930 2Drug side effects a key factor in reduced quality of life for kidney transplant patients 61930 3Amid the flu epidemic dont forget RSV in young children 61928 1Amid the flu epidemic dont forget RSV in young children 61928 2Amid the flu epidemic dont forget RSV in young children 61928 3
...ery from EAP in 2007, RICHMOND, Va., Jan. 24 Ins...biologics and biopharmaceuticals, today,provided a...(EAP) in Italy,for the treatment of Amyotrophic La...s grown to include 15 physicians and approximately...Additional subjects continue to be,enrolled into t...
...nt Rotavirus, NEW YORK, Jan. 23 Paul Capital Hea...yalty interest in Rotarix(R) from,Cincinnati Child...al,vaccine developed to prevent rotavirus infectio... and dehydration in infants and young children.,Th... has been approved in,over 100 countries including...
Other Medicine Technology:Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis 2Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis 3Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKline's Rotarix(R) 2
Halogen Lightsources
CMX2-300
NSL-8
NSL-5
Medicine Products: